Compare AANJANEYA LIFECARE with Sun Pharma - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SUN PHARMA - Comparison Results

SUN PHARMA 
   Change

Sun Pharma holds 3.7% share of the domestic pharma market (as per the latest ORG IMS MAT data) and has a strong presence in the lifestyle therapeutic segments. The company started focusing on the exports market in FY02, when it increased its stake to... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SUN PHARMA DR. DATSONS LABS/
SUN PHARMA
 
P/E (TTM) x -10.9 77.1 - View Chart
P/BV x 0.2 3.3 4.9% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 DR. DATSONS LABS   SUN PHARMA
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SUN PHARMA
Mar-20
DR. DATSONS LABS/
SUN PHARMA
5-Yr Chart
Click to enlarge
High Rs126484 25.9%   
Low Rs31315 9.8%   
Sales per share (Unadj.) Rs133.0136.9 97.2%  
Earnings per share (Unadj.) Rs0.217.5 0.9%  
Cash flow per share (Unadj.) Rs6.626.0 25.4%  
Dividends per share (Unadj.) Rs04.00 0.0%  
Dividend yield (eoy) %01.0 0.0%  
Book value per share (Unadj.) Rs128.8188.7 68.3%  
Shares outstanding (eoy) m31.662,399.26 1.3%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.62.9 20.1%   
Avg P/E ratio x516.122.9 2,253.6%  
P/CF ratio (eoy) x11.815.4 77.1%  
Price / Book Value ratio x0.62.1 28.7%  
Dividend payout %022.9 0.0%   
Avg Mkt Cap Rs m2,477958,864 0.3%   
No. of employees `000NA17.8 0.0%   
Total wages/salary Rs m5663,624 0.1%   
Avg. sales/employee Rs ThNM18,490.6-  
Avg. wages/employee Rs ThNM3,582.6-  
Avg. net profit/employee Rs ThNM2,357.6-  
INCOME DATA
Net Sales Rs m4,211328,375 1.3%  
Other income Rs m796,360 1.2%   
Total revenues Rs m4,289334,735 1.3%   
Gross profit Rs m56969,898 0.8%  
Depreciation Rs m20420,528 1.0%   
Interest Rs m4303,027 14.2%   
Profit before tax Rs m1352,702 0.0%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m0-2,606 0.0%   
Tax Rs m68,228 0.1%   
Profit after tax Rs m541,868 0.0%  
Gross profit margin %13.521.3 63.4%  
Effective tax rate %48.015.6 307.7%   
Net profit margin %0.112.8 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,852316,542 2.2%   
Current liabilities Rs m6,711157,064 4.3%   
Net working cap to sales %3.348.6 6.9%  
Current ratio x1.02.0 50.7%  
Inventory Days Days16188 183.7%  
Debtors Days Days318105 304.1%  
Net fixed assets Rs m3,673243,102 1.5%   
Share capital Rs m3172,399 13.2%   
"Free" reserves Rs m3,761450,245 0.8%   
Net worth Rs m4,078452,645 0.9%   
Long term debt Rs m1,67120,289 8.2%   
Total assets Rs m12,633682,525 1.9%  
Interest coverage x1.018.4 5.6%   
Debt to equity ratio x0.40 914.2%  
Sales to assets ratio x0.30.5 69.3%   
Return on assets %3.46.6 52.3%  
Return on equity %0.19.2 1.3%  
Return on capital %7.711.2 68.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m96474,219 1.3%   
Fx outflow Rs m60727,964 2.2%   
Net fx Rs m35746,255 0.8%   
CASH FLOW
From Operations Rs m1,34565,548 2.1%  
From Investments Rs m-2,256-25,888 8.7%  
From Financial Activity Rs m-1,200-57,151 2.1%  
Net Cashflow Rs m-2,111-13,857 15.2%  

Share Holding

Indian Promoters % 4.5 63.7 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 5.1 -  
FIIs % 1.4 23.0 5.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 8.3 1,133.7%  
Shareholders   20,807 133,026 15.6%  
Pledged promoter(s) holding % 0.0 0.5 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   WYETH  PIRAMAL ENTERPRISES  NATCO PHARMA  SHASUN PHARMA  PFIZER  

Compare DR. DATSONS LABS With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Sensex Ends 598 Points Lower, Nifty Settles Below 15,100-Mark; HDFC and JSW Steel Top Losers(Closing)

Indian share markets witnessed huge selling during closing hours today and ended their day deep in the red.

Related Views on News

SUN PHARMA Announces Quarterly Results (3QFY21); Net Profit Up 87.4% (Quarterly Result Update)

Feb 1, 2021 | Updated on Feb 1, 2021

For the quarter ended December 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 87.4% YoY). Sales on the other hand came in at Rs 88 bn (up 8.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA 2019-20 Annual Report Analysis (Annual Result Update)

Dec 11, 2020 | Updated on Dec 11, 2020

Here's an analysis of the annual report of SUN PHARMA for 2019-20. It includes a full income statement, balance sheet and cash flow analysis of SUN PHARMA. Also includes updates on the valuation of SUN PHARMA.

SUN PHARMA Announces Quarterly Results (2QFY21); Net Profit Up 66.9% (Quarterly Result Update)

Nov 6, 2020 | Updated on Nov 6, 2020

For the quarter ended September 2020, SUN PHARMA has posted a net profit of Rs 19 bn (up 66.9% YoY). Sales on the other hand came in at Rs 86 bn (up 5.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (4QFY20); Net Profit Down 31.6% (Quarterly Result Update)

May 28, 2020 | Updated on May 28, 2020

For the quarter ended March 2020, SUN PHARMA has posted a net profit of Rs 5 bn (down 31.6% YoY). Sales on the other hand came in at Rs 82 bn (up 14.3% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

SUN PHARMA Announces Quarterly Results (3QFY20); Net Profit Down 29.8% (Quarterly Result Update)

Feb 7, 2020 | Updated on Feb 7, 2020

For the quarter ended December 2019, SUN PHARMA has posted a net profit of Rs 10 bn (down 29.8% YoY). Sales on the other hand came in at Rs 82 bn (up 5.4% YoY). Read on for a complete analysis of SUN PHARMA's quarterly results.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps(Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market(Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

I Believe the Investment of the Year Will Be...

Feb 19, 2021

In this episode, ace trader Brijesh Bhatia talks to us about the best investments of 2021, his profitable trading system, and much more.

The Hidden Tesla in My Great Indian Wealth Project(Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - ALKEM LABORATORIES COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS